Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesA randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease
International Journal of STD & AIDS, 10/12/09
Heystek M et al. – Once–daily dosing and proven efficacy suggest that moxifloxacin may be of value in acute, uncomplicated PID.
Related Articles
Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09
Relevance Score: 70%
Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09
Relevance Score: 70%
Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history
Expert Review of Gastroenterology & Hepatology, 10/13/09
Relevance Score: 70%
Pregnancy and Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09
Relevance Score: 69%
Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease
World Journal of Gastroenterology, 11/13/09
Relevance Score: 69%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Investigational drugs for hepatitis C
Expert Opinion on Investigational Drugs, 12/15/09
Positive urine cultures: A major cause of inappropriate antimicrobial use in hospitals
Canadian Journal of Infectious Diseases, 12/15/09
Antiplasmodial and cytotoxic activity of khellactone derivatives from Angelica purpuraefolia chung
Phytotherapy Research, 12/15/09
Article Search
Sponsor